Cleared Traditional

K023320 - AGILTRAC .035 PERIPHERAL DILATATION CAT...

K023320 is the FDA 510(k) clearance for AGILTRAC .035 PERIPHERAL DILATATION CAT... by Guidant Corp.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K023320 · Guidant Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
67d
Days
Class 2
Risk

K023320 is an FDA 510(k) clearance for the AGILTRAC .035 PERIPHERAL DILATATION CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Guidant Corp. (Menlo Park, US). The FDA issued a Cleared decision on December 10, 2002 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guidant Corp. devices

Submission Details

510(k) Number K023320 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 2002
Decision Date December 10, 2002
Days to Decision 67 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 125d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 588
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K023320.
MODIFIED CONCENTRIC RETRIEVER, MODEL 90037
K030476 · Concentric Medical, Inc. · Mar 2003
ATTAIN 6216A-MP MULTI-PURPOSE GUIDE CATHETER FOR LEFT-HEART DELIVERY
K024032 · Medtronic Vascular · Dec 2002
ATTAIN 6218A-AM AMPLATZ GUIDE CATHETER FOR LEFT-HEART DELIVERY
K024035 · Medtronic Vascular · Dec 2002
8F LAUNCHER GUIDE CATHETER
K023402 · Medtronic Vascular · Nov 2002
ATB ALL-TERRAIN BALLOON PTA DILATATION CATHETER
K022552 · Cook, Inc. · Sep 2002
PTA AND PTV
K022722 · NuMED, Inc. · Sep 2002